Skip to main content
Signal8

Evolent Health, Inc. (EVH)

Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.

Sector: Services-Management Services

Industry: Medical - Healthcare Information Services

Evolent Health, Inc. logo

Evolent Health, Inc.

NYSE:EVHHealthcare
-1.84%$4.80
AH Close$4.80+0.00%vs close
Mkt Cap$542.68M
Float105.19M
O/S113.06M
Inst Own99.5%
SI12.3%
Dilution
Evolent Health, Inc. logoNYSE:EVH$4.80-1.84%
FormDescription
13G/A
Beneficial Ownership Report (Amended)
1
4
Statement of Changes in Beneficial Ownership
144
Notice of Proposed Sale of Securities
10-Q
8-K
13G
Beneficial Ownership Report
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
S-8
SEC Filing
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
8-K
5.07
10-Q
Quarterly Report
8-K
2.02,9.01
ARS
SEC Filing
DEFA14A
Additional Proxy Materials

1-25 of 855

…